# BIOS Capital Management, LP: Form 13F holdings

An institutional investment manager in Fort Worth, TX. SEC CIK 1813845.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $41.7m
- Positions: 6 (9 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1813845/000181384526000004/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ACTUATE THERAPEUTICS INC (ACTU)](/companies/actu.md) | COM | $15.4m | 36.9% | 10,049,996 |  | Unchanged |
| [OPUS GENETICS INC (IRD)](/companies/ird.md) | COM | $15.1m | 36.3% | 3,683,429 |  | Unchanged |
| [COGNITION THERAPEUTICS INC (CGTX)](/companies/cgtx.md) | COM | $6.9m | 16.6% | 6,000,000 |  | Unchanged |
| [REIN THERAPEUTICS INC (RNTX)](/companies/rntx.md) | COM NEW | $3.1m | 7.4% | 2,982,375 |  | Added +1,000,000 |
| [LANTERN PHARMA INC (LTRN)](/companies/ltrn.md) | COM | $1.0m | 2.5% | 249,397 |  | Reduced −615,038 |
| [IN8BIO INC (INAB)](/companies/inab.md) | COM NEW | $114.1k | 0.3% | 80,957 |  | Reduced −86,848 |

Source: SEC EDGAR, Form 13F-HR, accession 0001813845-26-000004. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.